top of page

Covid-19

COVID-19 vaccines available in the United States are effective at protecting people from getting seriously ill, being hospitalized, and dying. As with other vaccine-preventable diseases, you are protected best from COVID-19 when you stay up to date with the recommended vaccinations, including recommended boosters.

COVID-19 Boosters are classified in two categories: updated and original.

The updated boosters are called “updated” because they protect against both the original virus that causes COVID-19 and the Omicron variant BA.4 and BA.5. Two COVID-19 vaccine manufacturers, Pfizer and Moderna, have developed updated COVID-19 boosters.

​

Updated COVID-19 boosters became available on:

  • September 2, 2022, for people aged 12 years and older

  • October 12, 2022, for people aged 5–11 years

  • December 9, 2022, for children aged 6 months–4 years who completed the Moderna COVID-19 vaccine primary series.

 

Previous boosters are called “original” because they were designed to protect against the original virus that causes COVID-19. They also provide some protection against Omicron, but not as much as the updated boosters.

 

Types of Vaccines we offer and dosing:

 

Pfizer

Primary series for
12 years of age & older

The vaccine is administered as a primary series of 2 doses that are given
3 weeks apart.

1st Dose

FDA APPROVED

 

After 21 days or 3 weeks

2nd Dose

FDA APPROVED

 

AT LEAST 28 DAYS AFTER 2nd DOSE

3rd Dose FOR IMMUNOCOMPROMISED

FDA AUTHORIZED

For individuals with certain kinds of immunocompromise, a third primary series dose may be administered at least 28 days after the second dose.

 

Bivalent Booster:

Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5)* was designed as a response to increasing rates of infection caused by certain COVID-19 variants—in particular the Omicron variant BA.4/BA.5.

*Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5) is referred to as
Pfizer-BioNTech COVID-19 Vaccine, Bivalent.

The bivalent booster is available as:

A single booster dose for people 5 years of age and older administered at least
2 months after:

  • Completion of primary vaccination with any authorized or approved monovalent† COVID-19 vaccine; or

  • Receipt of the most recent booster dose with any authorized or approved monovalent† COVID-19 vaccine.

 

 

Moderna

Moderna/Spikevax are only offered in booster doses.

 

Bivalent Booster to be administered at least 2 months after primary series.  

 

For inform on Moderna vaccine, please visit: https://www.spikevax.com

 

When Are You Up to Date?

You are up to date with your COVID-19 vaccines when you have completed a COVID-19 vaccine primary series and got the most recent booster dose recommended for you by CDC.

 

If you have completed your primary series—but are not yet eligible for a booster—you are also considered up to date.

If you become ill with COVID-19 after you received all COVID-19 vaccine doses recommended for you, you are also considered up to date. You do not need to be revaccinated or receive an additional booster.

 

COVID-19 vaccine recommendations are based on three things:

  1. Your age

  2. The vaccine you first received, and

  3. The length of time since your last dose

 

Getting Vaccines If You Had or Currently Have COVID-19

If you recently had COVID-19, you still need to stay up to date with your vaccines, but you may consider delaying your next vaccine dose (whether a primary dose or booster) by 3 months from:

  • when your symptoms started.

  • Or, if you had no symptoms, when you first received a positive test.

 

Reinfection is less likely in the weeks to months after infection. However, certain factors could be reasons to get a vaccine sooner rather than later, such as:

​​

Click here to schedule a COVID-19 home visit

​​

​

bottom of page